《盈利預喜》丘鈦(01478.HK)料上半年純利增40-60% 下修攝像頭模組出貨量增長目標
丘鈦科技(01478.HK)發盈喜,料上半年純利將按年增長40-60%,而去年同期賺3.36億元人民幣,期內純利增加主要因為攝像頭模組產品結構繼續優化,攝像頭模組產品附加值增加;全自動數字化智能工廠改造的成效進一步展現;攝像頭模組和指紋識別模組產品銷售數量均實現穩健增長,產能利用率提升。
另外,公司宣布修改攝像頭模組出貨數量目標,主要因為去年業績公告所訂的出貨數量目標將面臨較大挑戰,故將目標修訂為「努力實現2021年度攝像頭模組出貨數量較上年度同比增長不低於25%」,而較早前增長目標為不低於30%。(el/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.